Apogee
Therapeutics
Refusing to stop at “good enough”
Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment. Our unique scientific approach is enabling us to explore treatment options that have the potential to work better, longer.
Our Programs
Our pipeline of novel antibody therapeutics targets well-established biological drivers and development pathways and has the potential to treat numerous dermatological, respiratory, and gastroenterological conditions.
Patients
& Caregivers
At Apogee, we are committed to the patients and caregivers that we serve. We are developing a suite of potentially differentiated therapies to improve the lives of people living with I&I conditions.
People first, always
We strongly believe the best thing we can do for fellow teammates and people living with inflammatory and immune diseases is to create an environment of psychological safety, where everyone feels comfortable sharing different ideas and ultimately coming to the best answer together.
Our Team
Our team is comprised of experienced clinical and commercial leaders, drug developers, scientists, physicians, and operators who never accept “good enough” and are highly motivated to build medicines for life.
